Clinic Events Radiation Radiation Oncology 
AuntMinnie
SEPTEMBER 30, 2024
A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. The researchers also tracked overall survival and rates of adverse events.
Imaging Technology
SEPTEMBER 13, 2023
associate professor of Radiation Oncology. “IMRT spared more normal tissue than 3D-CRT, which translated into a clinically meaningful benefit to patients,” Chun said. This trial was funded by the National Cancer Institute (R50CA275822, U10CA21661, U10CA180868, and U10CA180822), Bristol Myers Squibb and Eli Lilly and Company.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
AUGUST 8, 2024
5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients with oligometastatic pancreatic cancer. assistant professor of Gastrointestinal Radiation Oncology. “We
Imaging Technology
MAY 6, 2024
This strategic move bolsters Elekta’s position in treatment planning and underscores its commitment to being the innovation leader in radiation therapy. Martijn Hartjes , Business Leader Clinical Informatics at Philips, added: “We are pleased that we can continue to support our customers with leading solutions in radiation oncology.
AuntMinnie
JULY 12, 2024
Beyder, along with Vikas Prasad, MD, PhD, and BJH/WU Radiation Oncology all played an integral role in launching the SNMMI radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, Barnes-Jewish Hospital, and Siteman Cancer Center last year. Involve radiation safety early in your therapy center development. "If
Imaging Technology
SEPTEMBER 29, 2023
milla1cf Fri, 09/29/2023 - 17:00 September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.
Imaging Technology
APRIL 29, 2024
a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center , aims to demonstrate the feasibility of PGHD collection during proton beam radiotherapy for lung cancer. These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy.
Expert insights. Personalized for you.
119 
Let's personalize your content